(Q47867429)

6 February 2018

title

Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. (English)

1 reference

6 February 2018

0 references

3

Rafaela Holtappels

1 reference

6 February 2018

author name string

Véronique Mersseman

1

1 reference

6 February 2018

Verena Böhm

2

1 reference

6 February 2018

Petra Deegen

4

1 reference

6 February 2018

Uwe Wolfrum

5

1 reference

6 February 2018

Bodo Plachter

6

1 reference

6 February 2018

Sabine Reyda

7

1 reference

6 February 2018

publication date

5 March 2008

1 reference

6 February 2018

Medical Microbiology and Immunology

published in

1 reference

6 February 2018

volume

197

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

97-107

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s00430-008-0085-2

exact match

0 references

cites work

Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00430-008-0085-2

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients

21 January 2018

1 reference

12 December 2020

Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response

1 reference

12 December 2020

Protein delivery by subviral particles of human cytomegalovirus

1 reference

12 December 2020

Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence

1 reference

12 December 2020

Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus

1 reference

12 December 2020

Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort

1 reference

12 December 2020

Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.

1 reference

12 December 2020

Human bone marrow fibroblasts infected by cytomegalovirus: ultrastructural observations

1 reference

12 December 2020

CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation

1 reference

12 December 2020

Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response

1 reference

12 December 2020

Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.

1 reference

12 December 2020

Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects.

1 reference

12 December 2020

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity

1 reference

12 December 2020

Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting

1 reference

12 December 2020

Human cytomegalovirus vaccine: time to look for alternative options.

1 reference

12 December 2020

Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome

1 reference

12 December 2020

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

1 reference

12 December 2020

Human cytomegalovirus DNA: BamHI, EcoRI and PstI restriction endonuclease cleavage maps

1 reference

12 December 2020

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines

1 reference

12 December 2020

Recombinant viruses as tools to study human cytomegalovirus immune modulation

1 reference

12 December 2020

Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies.

1 reference

12 December 2020

Simple and highly efficient BAC recombineering using galK selection

1 reference

12 December 2020

Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues

1 reference

12 December 2020

Clinical aspects of CMV infection after stem cell transplantation

1 reference

12 December 2020

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

1 reference

12 December 2020

Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs

1 reference

12 December 2020

Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response

1 reference

12 December 2020

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

1 reference

12 December 2020

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

1 reference

12 December 2020

Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus

1 reference

12 December 2020

The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture

1 reference

12 December 2020

Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles

1 reference

12 December 2020

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

1 reference

12 December 2020

Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization

1 reference

12 December 2020

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

1 reference

12 December 2020

A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA

1 reference

12 December 2020

Congenital cytomegalovirus (CMV) infection and hearing deficit

1 reference

12 December 2020

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

1 reference

12 December 2020

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

12 December 2020

Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products

1 reference

12 December 2020

Cellular immunotherapy for viral infection after HSC transplantation

1 reference

12 December 2020

Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression

1 reference

12 December 2020

Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus

1 reference

12 December 2020

Vaccine strategies against human cytomegalovirus infection.

1 reference

12 December 2020

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

12 December 2020

Progress toward an elusive goal: current status of cytomegalovirus vaccines

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

10.1007/S00430-008-0085-2

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

18320219

1 reference

6 February 2018